The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BrainStorm: A brain metastases research platform to tackle the challenge of central nervous system (CNS) metastases in solid tumors (Oncodistinct 006).
 
Nuria Kotecki
No Relationships to Disclose
 
Maria Alice B Franzoi
No Relationships to Disclose
 
Marianne Paesmans
No Relationships to Disclose
 
Florian Clatot
Honoraria - AstraZeneca; BMS; BMS; Merck Serono; Merck Serono; Merck Serono
Consulting or Advisory Role - BMS; Lilly; Lilly; Merck Serono; Merck Serono; Roche
Research Funding - AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BMS; BMS; Merck Serono; Roche
 
Edith Borcoman
No Relationships to Disclose
 
Anthony Goncalves
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Cascadian Therapeutics (Inst); Lilly (Inst); Merus (Inst); MSD (Inst); Nektar (Inst); Novartis (Inst); Roche (Inst); Roche/Genentech (Inst); Sanofi/Aventis (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Novartis
 
Philippe Barthelemy
Honoraria - Astellas Pharma; EUSA Pharma
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Pfizer; Roche
 
Claire Cheymol
Travel, Accommodations, Expenses - Pfizer
 
Jean-Pierre Delord
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Novartis; Roche/Genentech (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); MSD Oncology (Inst); Transgene (Inst)
 
Andrea Gombos
Consulting or Advisory Role - Daiichi Sankyo (Inst); Lilly (Inst)
 
Vincent Vanhaudenarde
No Relationships to Disclose
 
Stephane Holbrechts
No Relationships to Disclose
 
Francois P. Duhoux
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Pfizer; Roche; Teva
 
Jean-Luc Re Canon
Consulting or Advisory Role - Daiichi Sankyo; Lilly; Roche
Research Funding - Roche (Inst)
 
Lore Decoster
Consulting or Advisory Role - AstraZeneca (Inst); BMS Belgium (Inst); MSD Belgium (Inst)
Speakers' Bureau - AstraZeneca (Inst); MSD Belgium (Inst)
Research Funding - Boehringer Ingelheim (Inst)
Travel, Accommodations, Expenses - MSD Belgium (Inst); Roche Belgium (Inst)
 
Hannelore denys
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst)
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Teva (Inst)
 
Caroline Duhem
No Relationships to Disclose
 
Nadège Kindt
No Relationships to Disclose
 
Ahmad Awada
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Daiichi Sankyo/Lilly; Eisai; Genomic Health; Ipsen; LEO Pharma; Lilly; Merck Serono; MSD; Novartis; Pfizer; Roche